The Scientist

» gene patent and immunology

Most Recent

image: Inflammation for Regeneration

Inflammation for Regeneration

By | November 8, 2012

Inflammatory signals in injured zebrafish brains promote the growth of new neurons.

1 Comment

image: Bacterial Cocktail Treats Infection

Bacterial Cocktail Treats Infection

By | October 29, 2012

Mice fed a mix of six strains of bacteria were able to fight a C. difficile infection that causes deadly diarrhea and is resistant to most types of treatment.

2 Comments

image: Ancient Viruses Wreak New Havoc

Ancient Viruses Wreak New Havoc

By | October 24, 2012

Viral DNA in mice genomes may lead to cancer in immune-compromised animals.

0 Comments

image: Drug Allergy in the Pocket

Drug Allergy in the Pocket

By | October 1, 2012

An HIV drug can bind to and alter the function of an immune molecule, causing a dangerous reaction in patients with a particular allele.

0 Comments

image: 2012 Labbies Honorable Mentions

2012 Labbies Honorable Mentions

By | October 1, 2012

Check out other memorable images and videos that were submitted to this year’s Labby Multimedia Awards.

0 Comments

image: A Good Night’s Sleep

A Good Night’s Sleep

By | September 1, 2012

Sleep-wake cycles affect how well our bodies fight disease.

0 Comments

image: The Danger of Vaccine Exemptions

The Danger of Vaccine Exemptions

By | August 30, 2012

Are states with less rigorous rules about which children can claim an exception from vaccination in kindergarten putting communities at higher risk of childhood disease?

4 Comments

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Cancer-Causing Gut Bacteria

Cancer-Causing Gut Bacteria

By | August 17, 2012

Mice with inflammatory bowel disease harbor gut bacteria that damage host DNA, predisposing mice to cancer.

1 Comment

image: Court Rules Gene Patents Valid

Court Rules Gene Patents Valid

By | August 17, 2012

Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.

8 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech